ghk cu peptide dosage injection The GHK-cu Masterclass ghk cu daily dosage injection

Jorsal T, Rungby J, Knop FK, Vilsbll T

What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect

DHT produces many of its effects through TGF-1

A 27 to 29 gauge needle is the clinical standard for subcutaneous peptide injection

Sci Total Environ 645:14001409

, Stable Gastric Pentadecapeptide BPC 157 and Wound Healing, Frontiers Media SA, Jun